Australian Health Ministers sign on to end HIV transmissions by 2020

21 July 2014
canberra-big

All Australian Health Ministers have committed to working towards the virtual elimination of new Australian HIV transmissions by the end of 2020, said the Department of Health and Ageing over the weekend.

The AIDS 2014 Legacy Statement, which was agreed by all Health Ministers in Australia when they met in June, commits each of the nine jurisdictions – the Australian government and the eight States and Territories – to take all necessary action, in partnerships with key affected communities and sector partners, to remove barriers to testing, treatment, prevention, care and support, across legal, regulatory, policy, social, political and economic domains.

Australia has a strong record of non-partisan leadership in responding to the HIV epidemic - resulting in one of the lowest prevalence rates in the world. However, HIV cases are increasing and to discuss what is needed to reinvigorate the Australian response, in February 2014, a national Roundtable was convened with community, research and scientific leaders. The outcome of this roundtable was the development of this exciting and ambitious Legacy Statement.

Australia needs to take advantage of advances in anti-viral treatment

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical